Researchers from University College London have identified two new biological subtypes of multiple sclerosis (MS) using AI, which could lead to more personalized treatments. The study analyzed data from 600 MS patients, revealing 'early sNfL' and 'late sNfL' subtypes based on blood protein levels and MRI scans. This discovery may enhance diagnosis and treatment strategies for MS, allowing for better prediction of disease progression and tailored therapies. Teljes cikk (Euronews.com)